BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18822713)

  • 1. [Docetaxel in the inductive therapy of head and neck cancer: recent evidence].
    Benasso M; Corvò R
    Tumori; 2008; 94(4):suppl 24-5. PubMed ID: 18822713
    [No Abstract]   [Full Text] [Related]  

  • 2. Docetaxel with concurrent radiotherapy in head and neck cancer.
    Nabell L; Spencer S
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):89-93. PubMed ID: 14727247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The viewpoint of the medical oncologist].
    Benasso M
    Tumori; 2008; 94(4):suppl 26-9. PubMed ID: 18822714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Docetaxel: a new weapon in the treatment of head and neck tumors].
    Melano M
    Tumori; 2001; 87(6):A9-10. PubMed ID: 11995709
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of docetaxel in the management of squamous cell cancer of the head and neck.
    Glisson BS
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):83-7. PubMed ID: 12108901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant docetaxel-based treatment for breast cancer.
    Tilstone C
    Lancet Oncol; 2007 Jan; 8(1):15. PubMed ID: 17348121
    [No Abstract]   [Full Text] [Related]  

  • 7. Head and neck cancers: making headway in their treatment?
    McCann J
    J Natl Cancer Inst; 2000 Jan; 92(1):11-3. PubMed ID: 10620623
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
    Altundag O; Altundag K; Morandi P; Hanrahan E
    Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
    [No Abstract]   [Full Text] [Related]  

  • 9. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
    Bernier J; Vrieling C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
    Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV
    Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
    Parthan A; Posner MR; Brammer C; Beltran P; Jansen JP
    Head Neck; 2009 Oct; 31(10):1255-62. PubMed ID: 19731394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More lessons learned from the suffocation of hypoxia.
    Ang KK
    J Clin Oncol; 2010 Jun; 28(18):2941-3. PubMed ID: 20479396
    [No Abstract]   [Full Text] [Related]  

  • 14. Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer.
    Oncology (Williston Park); 1996 Mar; 10(3):422. PubMed ID: 8820455
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.
    Hambek M; Werner C; Baghi M; Gstöttner W; Knecht R
    Eur J Cancer; 2007 Jul; 43(10):1502-7. PubMed ID: 17524637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers.
    Awada A; Lalami Y
    Curr Opin Oncol; 2005 May; 17(3):209-11. PubMed ID: 15818162
    [No Abstract]   [Full Text] [Related]  

  • 17. [Randomizations!].
    Piedbois P; Buyse M
    Cancer Radiother; 1998 Dec; 2(6):663-4. PubMed ID: 9922769
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study.
    Noronha V; Goswami C; Patil S; Joshi A; Patil VM; Murthy V; Arya S; Juvekar S; Goud S; Prabhash K
    J Laryngol Otol; 2016 Sep; 130(9):833-42. PubMed ID: 27456399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining radiotherapy with systemic therapies.
    Vokes EE
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: induction chemotherapy for head and neck cancer: hypothesis-based rather than evidence-based medicine.
    Eisbruch A
    Oncologist; 2007 Aug; 12(8):975-7. PubMed ID: 17766657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.